J. Mark Hexham

1.8k citations

25 papers · 1.1k indexed · h-index 16

Impact in

Transplantation top 1%
- Renal Transplantation Outcomes and Treatments
Hepatology top 5%
- Liver Disease and Transplantation

Papers in ⓘ

Transplantation 11
- Renal Transplantation Outcomes and Treatments 11
Biotechnology 5
- Transgenic Plants and Applications 5

Co-authors: U. Fritsche (1 shared paper)Michael J. Geisow (1 shared paper)Michaël J. Crumpton (4 shared papers)J. Donald Capra (2 shared papers)Leon Carayannopoulos (1 shared paper)Denis R. Alexander (2 shared papers)Doreen A. Cantrell (2 shared papers)G. Junge (6 shared papers)
Journals: American Journal of Transplantation (3 papers)Biochemical Journal (2 papers)The Journal of Experimental Medicine (2 papers)Pediatric Transplantation (2 papers)Transplantation (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

J. Mark Hexham

25 papers receiving 1.1k citations

Peers

Countries citing papers authored by J. Mark Hexham

Since Specialization

Citations

This map shows the geographic impact of J. Mark Hexham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mark Hexham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mark Hexham more than expected).

Fields of papers citing papers by J. Mark Hexham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mark Hexham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mark Hexham. The network helps show where J. Mark Hexham may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Mark Hexham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Mark Hexham Line = papers co-authored together J. Mark Hexham links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A consensus amino-acid sequence repeat in Torpedo and mammalian Ca2+-dependent membrane-binding proteins Nature ·Michael J. Geisow, U. Fritsche, J. Mark Hexham, B.C.J. Dash, Tolu Johnson	1986	277
2	Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial American Journal of Transplantation ·Paolo De Simone, Frank Nevens, Luciano De Carlis, Herold J. Metselaar, Susanne Beckebaum, Faouzi Saliba, Sven Jonas, Debra L. Sudan, John J. Fung, Lutz Fischer, Christophe Duvoux, Kenneth D. Chavin, Baburao Koneru, Mengyang Huang, William C. Chapman, Daniel Foltys, S. Witte, Hong Jiang, J. Mark Hexham, G. Junge	2012	235
3	Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1. The Journal of Experimental Medicine ·Leon Carayannopoulos, J. Mark Hexham, J. Donald Capra	1996	79
4	Everolimus With Reduced Cyclosporine Versus MMF With Standard Cyclosporine in De Novo Heart Transplant Recipients Transplantation ·H. Lehmkuhl, José M. Arizón, Mario Viganò, Luís Almenar, Gino Gerosa, Massimo Maccherini, Shaïda Varnous, Francesco Musumeci, J. Mark Hexham, Kevin C. Mange, Ugolino Livi	2009	70
5	A protein kinase C pseudosubstrate peptide inhibits phosphorylation of the CD3 antigen in streptolysin-O-permeabilized human T lymphocytes Biochemical Journal ·Denis R. Alexander, J. Mark Hexham, S C Lucas, Jonathan D. Graves, Doreen A. Cantrell, Michaël J. Crumpton	1989	56
6	Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion Protein Engineering Design and Selection ·Jerry Thompson, Scott Stavrou, Marla Weetall, J. Mark Hexham, Mary Ellen Digan, Zhuri Wang, Jung Hee Woo, Yongjun Yu, Askale Mathias, Yuan Yi Liu, Shenglin Ma, Irina Gordienko, Philip Lake, David M. Neville	2001	49
7	The human T3 gamma chain is phosphorylated at serine 126 in response to T lymphocyte activation. Journal of Biological Chemistry ·Adelina A. Davies, Doreen A. Cantrell, J. Mark Hexham, Peter J. Parker, Jonathan Rothbard, Michaël J. Crumpton	1987	47
8	Homology between the subunits of S100 and a 10kDa polypeptide associated with p36 of pig lymphocytes Biochemical and Biophysical Research Communications ·J. Mark Hexham, Nicholas F. Totty, Michael D. Waterfield, Michaël J. Crumpton	1986	41
9	A Human Immunoglobulin (Ig)A Cα3 Domain Motif Directs Polymeric Ig Receptor–mediated Secretion The Journal of Experimental Medicine ·J. Mark Hexham, Kendra D. White, Leonidas N. Carayannopoulos, Wlodeck Mandecki, Renee Brisette, Yih-Sheng Yang, J. Donald Capra	1999	39
10	The association of type 1, type 2A and type 2B phosphatases with the human T lymphocyte plasma membrane Biochemical Journal ·Denis R. Alexander, J. Mark Hexham, Michaël J. Crumpton	1988	34
11	Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins Molecular Immunology ·J. Mark Hexham, Debra Dudas, Ron Hugo, Jerry Thompson, Vicki King, Carol E. Dowling, David M. Neville, Mary Ellen Digan, Phil Lake	2001	28
12	Multicenter trial of everolimus in pediatric renal transplant recipients: Results at three year Pediatric Transplantation ·Robert B. Ettenger, Peter‐Friedrich Hoyer, Paul C. Grimm, Nicholas J.A. Webb, Chantal Loirat, John D. Mahan, Mark Mentser, Patrick Niaudet, G. Offner, R. Vandamme‐Lombaerts, J. Mark Hexham, (unknown)	2008	26
13	Cloning of A Human Autoimmune Response: Preparation and Sequencing of A Human Anti-Thyroglobulin Autoantibody Using A Combinatorial Approach Autoimmunity ·J. Mark Hexham, Jadwiga Furmaniak, C. A. S. Pegg, Dennis R. Burton, B R Smith	1992	24
14	Efficacy and safety of SBR759, a novel calcium‐free, iron(III)‐based phosphate binder, in Asian patients undergoing hemodialysis: A 12‐week, randomized, open‐label, dose‐titration study versus sevelamer hydrochloride Nephrology ·J. F. Chen, Shou-Shan Chiang, HUNG‐CHUN CHEN, Seiichi Obayashi, Masaki Nagasawa, J. Mark Hexham, Alison Balfour, G. Junge, Takashi Akiba, Masafumi Fukagawa	2011	21
15	TRANSFORM: a novel study design to evaluate the effect of everolimus on long-term outcomes after kidney transplantation INFM-OAR (INFN Catania) ·Julio Pascual, Titte R. Srinivas, Steven J. Chadban, Franco Citterio, Federico Oppenheimer, Hélio Tedesco‐Silva, Mitchell L. Henry, Christophe Legendre, Yoshihiko Watarai, Claudia Sommerer, Wen‐Jeng Lee, J. Mark Hexham, Gaohong Dong, Peter Bernhardt, Flavio Vincenti	2014	21
16	Strategies for Liver Transplantation Tolerance International Journal of Molecular Sciences ·Filip Cvetkovski, J. Mark Hexham, Erik Berglund	2021	17
17	A high-capacity alkaline phosphatase reporter system for the rapid analysis of specificity and relative affinity of peptides from phage-display libraries Journal of Immunological Methods ·Richard M. Wright, Debra Dudas, Brian Gavin, Diane Dottavio, J. Mark Hexham, Phil Lake	2001	9
18	De novo therapy with everolimus and reduced‐exposure cyclosporine following pediatric kidney transplantation: A prospective, multicenter, 12‐month study Pediatric Transplantation ·Carl M. Grushkin, John D. Mahan, Kevin C. Mange, J. Mark Hexham, Robert B. Ettenger	2012	8
19	Renal function with everolimus and reduced tacrolimus in de novo liver transplant recipients: 12 month results of the H2304 trial. O-17 Liver Transplantation ·Paolo De Simone, Frederik Nevens, Luciano De Carlis, H.J. Metselaar, Susanne Beckebaum, Faouzi Saliba, Sven Jonas, Debra L. Sudan, L. Fischer, Daniel Foltys, Baburao Koneru, Y Wang, J. Mark Hexham, G. Junge, John J. Fung	2012	5
20	Production of Human Fab Antibody Fragments from Phage Display Libraries Methods in molecular biology ·J. Mark Hexham	1998	4

About J. Mark Hexham

J. Mark Hexham is a scholar working on Transplantation, Biotechnology, Immunology, Radiology, Nuclear Medicine and Imaging and Psychiatry and Mental health, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Organ Transplantation Techniques and Outcomes (7 papers), Transgenic Plants and Applications (5 papers), Toxin Mechanisms and Immunotoxins (4 papers), Glycosylation and Glycoproteins Research (4 papers), Neurological Complications and Syndromes (4 papers) and Transplantation: Methods and Outcomes (3 papers). The work is most often cited by research in Transplantation (311 citations), Hepatology (147 citations), Immunology (262 citations), Radiology, Nuclear Medicine and Imaging (181 citations) and Surgery (319 citations). J. Mark Hexham has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include U. Fritsche, Michael J. Geisow, Michaël J. Crumpton, J. Donald Capra, Leon Carayannopoulos, Denis R. Alexander, Doreen A. Cantrell, G. Junge, Debra L. Sudan and Luciano De Carlis. Their work appears in journals such as American Journal of Transplantation, Biochemical Journal, The Journal of Experimental Medicine, Pediatric Transplantation and Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact